Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cayratia japonica is a perennial, herbaceous vine in the grape family (Vitaceae), native to tropical and subtropical Asia, Australia, and the West Pacific. It is widely used in traditional Chinese medicine and other Asian folk medicines for its anti-inflammatory, diuretic, detoxifying, antipyretic (fever-reducing), and wound-healing properties. The plant contains bioactive compounds such as luteolin-7-O-glucoside that have been shown to promote wound healing by activating AMPK/CTHRC1/TGF-β1 signaling pathways. Traditionally, various parts of the plant are used to treat swelling, fever (including malaria), rheumatism, headaches, diarrhoea, mumps, jaundice, dysentery, constipation and traumatic injuries. It is also consumed as food; young leaves and flowers can be eaten raw or cooked[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cayratia japonica.